Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias

被引:35
作者
Verduyn, SC [1 ]
Vos, MA [1 ]
Leunissen, HDM [1 ]
van Opstal, JM [1 ]
Wellens, HJJ [1 ]
机构
[1] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6202 AZ Maastricht, Netherlands
关键词
dronedarone; amiodarone; almokalant; dog; electrophysiology; repolarization; arrhythmias; triggered activity; early afterdepolarizations; monophasic action potentials; ventricle;
D O I
10.1097/00005344-199902000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the anesthetized dog with complete chronic AV block (CAVB), we evaluated and compared the acute electrophysiologic effects of dronedarone i.v. (Dron, 2 times 2.5 mg/kg/10 min) and amiodarone i.v. (Amio, 2 times 5 mg/kg/10 min). This canine model with a high sensitivity for acquired torsade de pointes (TdP) provides an ideal substrate to evaluate ventricular repolarization abnormalities. Six ECG leads and two endocardial monophasic action potential (MAP) recordings in the left and right ventricle (LV and RV) were simultaneously recorded to measure QT time, action-potential duration (APD), interventricular dispersion (Delta APD = LVAPD - RVAPD) early afterdepolarizations (EADs), ectopic beats (EBs), and TdP. Measurements were made at the spontaneous idioventricular rhythm (IVR) and 1,000-ms steady-state pacing. To investigate its short-term, antiarrhythmic properties, Dron was given after almokalant (0.12 mg/kg)-induced TdP. Furthermore, in another set of experiments, oral Dron (20 mg/kg, b.i.d) was given for 3 weeks to conscious CAVE dogs. Dron, i.v., shortened ventricular repolarization (QT, 435 +/- 60 to 360 +/- 55; LVAPD, 395 +/- 75 to 335 +/- 60 ms; p < 0.05), whereas IVR and ventricular effective refractory period (VERP, 225 +/- 30 to 230 +/- 30 ms) remained similar. Therefore the VERP/QT ratio increased (0.55 +/- 0.04 to 0.61 +/- 0.03; p < 0.05). Similar results were obtained with Amio, i.v.. Almokalant-induced TdP was characterized by an increased repolarization duration, Delta APD, and EADs. Dron, i.v., suppressed the EADs, EBs, and TdP by a reduction and homogenization of repolarization (LVAPD, 505 +/- 110 to 455 +/- 80 ms, and Delta APD, 110 +/- 55 to 65 +/- 40 ms). Long-term oral Dron increased the PP interval, CL-IVR, and QT((c)) time. Tn contrast to oral treatment, Dron i.v. shortens ventricular repolarization parameters, resulting in suppression of EAD-dependent acquired TdP. The increased VERP/QT ratio after Dron i.v. may indicate an important second antiarrhythmic property.
引用
收藏
页码:212 / 222
页数:11
相关论文
共 45 条
[11]  
GREENE HL, 1993, AM J CARDIOL, V72, P280
[12]  
Harris L, 1986, AMIODARONE PHARM PHA
[13]   PRECORDIAL QT INTERVAL DISPERSION AS A MARKER OF TORSADE-DE-POINTES - DISPARATE EFFECTS OF CLASS IA ANTIARRHYTHMIC DRUGS AND AMIODARONE [J].
HII, JTY ;
WYSE, DG ;
GILLIS, AM ;
DUFF, HJ ;
SOLYLO, MA ;
MITCHELL, B .
CIRCULATION, 1992, 86 (05) :1376-1382
[14]   SR-33589, A NEW AMIODARONE-LIKE ANTIARRHYTHMIC AGENT - ANTI-ADRENOCEPTOR ACTIVITY IN ANESTHETIZED AND CONSCIOUS DOGS [J].
HODEIGE, D ;
HEYNDRICKX, JP ;
CHATELAIN, P ;
MANNING, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 279 (01) :25-32
[15]  
HODEIGE D, 1994, INT SOC HEART RES EU, P681
[16]   PROARRHYTHMIA WITH CLASS-III ANTIARRHYTHMIC DRUGS - DEFINITION, ELECTROPHYSIOLOGIC MECHANISMS, INCIDENCE, PREDISPOSING FACTORS, AND CLINICAL IMPLICATIONS [J].
HOHNLOSER, SH ;
SINGH, BN .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1995, 6 (10) :920-936
[17]   ACUTE EFFECTS OF INTRAVENOUS PRIFUROLINE AND AMIODARONE ON CANINE CARDIAC AUTOMATICITY, CONDUCTION, AND REFRACTORINESS [J].
JAILLON, P ;
HECKLE, J ;
JAIS, JM ;
POVEDASIERRA, J ;
CHEYMOL, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :486-492
[18]   Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT [J].
Julian, DG ;
Camm, AJ ;
Frangin, G ;
Janse, MJ ;
Munoz, A ;
Schwartz, PJ ;
Simon, P .
LANCET, 1997, 349 (9053) :667-674
[19]   Cellular electropharmacology of amiodarone [J].
Kodama, I ;
Kamiya, K ;
Toyama, J .
CARDIOVASCULAR RESEARCH, 1997, 35 (01) :13-29
[20]   RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS AMIODARONE AND BRETYLIUM IN THE TREATMENT OF PATIENTS WITH RECURRENT, HEMODYNAMICALLY DESTABILIZING VENTRICULAR-TACHYCARDIA OR FIBRILLATION [J].
KOWEY, PR ;
LEVINE, JH ;
HERRE, JM ;
PACIFICO, A ;
LINDSAY, BD ;
PLUMB, VJ ;
JANOSIK, DL ;
KOPELMAN, HA ;
SCHEINMAN, MM .
CIRCULATION, 1995, 92 (11) :3255-3263